Company record
Ralph A. DeFronzo, M.D.
1 FDA warning letter since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about Ralph A. DeFronzo, M.D..
Warning letters
-
DrugsRalph A. DeFronzo, M.D.
FDA warns Dr. Ralph A. DeFronzo for enrolling ineligible subjects and failing to promptly report study changes to the IRB.
High risk